Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in cipla

Cipla First Quarter Profit Rises 20%, Beats Estimates

Revenue from South Africa, Cipla's third largest market, rose 21 per cent to Rs 4.88 billion compared with last year while Europe revenues climbed 33 per cent to Rs 1.58 billion

Read More

Cipla: Legends & Legacies

Cipla has always fought against unjustified market monopolies by MNC giants and has boldly launched cheaper generic drugs

Read More

On The Offensive

The future lies in innovation and building businesses in chosen therapeutic categories

Read More

No One Should Be Denied Medicine, Says Cipla Chairman

Hamied offers free knowhow for essential drugs, promises Cipla will continue to provide affordable medicines

Read More

Cipla Appoints Peter Lankau As Independent Director

Cipla, a global pharmaceutical company announces the appointment of Peter Lankau as an independent director on its board with effect from January 10

Read More

Cipla Q2 Profit Falls As Europe, Emerging Markets Suffer

Sales in India, Cipla's biggest market, rose 21 per cent in the quarter, the company said in a statement

Read More

Drug Firms Facing Challenging Times Due To Price Control: Cipla

Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products

Read More

Cipla In A State Of Flux

The pharma major has been moulting since 2012, but will the recent management rejig jolt the transformation?

Read More

Cipla, Wockhardt In Talks For A Broader Business Alliance

The alliance, which may even lead to a merger or equity collaboration between the two drugmakers, is expected to be announced soon

Read More

Cipla First Quarter Profit Lags Estimates; Names New CEO

The company reported a lower-than-expected quarterly profit as revenues in its home market were hit by government measures to cut drug prices

Read More

Cipla To Set Up South Africa’s First Biopharma Facility

Drug firm Cipla will invest around Rand 1.3 billion (over Rs 590 crore) to launch a manufacturing facility in South Africa for the production of biosimilars

Read More

Cipla, Wockhardt And Pfizer Among Top Winners At DigiPharmaX 2016

The awards recognise the excellence in Digital in the Pharma industry and is the country's first award of this kind

Read More

India Approves First Stem Cell-based Drug For Buerger's Disease

The drug controller general of India has granted limited approval to Stempeutics Research, a joint venture between drug maker Cipla and Manipal Group for manufacturing and marketing its stem cell based biological drug Stempeucel for the treatment of Buerger’s Disease

Read More

Analysts Cut Cipla 2017 Estimate After Weak Q4 Show

Cipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs

Read More

Delhi High Court Extends Relief To Pharma Firms In Drug Ban Case

The Delhi High Court restrained the government from enforcing a ban on hundreds of drugs for another week on Monday until it has heard petitions from drugmakers challenging the order

Read More